Press-release for stocks related to merge for johnson & johnson

tags : Merge entities : Johnson & johnson

save search

Emergent BioSolutions Reports Financial Results for Fourth Quarter 2021
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -10.09% | O: -1.05% H: 0.0% C: 0.0%
EBS | $2.04 9.68% 0.49% 930K

Health Technology

| -95.62% | O: -1.65% H: 0.0% C: 0.0%
financial results solutions report results merge

JPM Day 4: Battered Emergent Solutions Looks Ahead, Vir and Thermo Fisher
Published: 2022-01-14 (Crawled : 19:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -14.48% | O: -0.53% H: 0.0% C: 0.0%
merge

Global $24.26 Bn Rheumatoid Arthritis Markets Analysis & Forecasts, 2016-2020 & 2021-2026 - Competitive Developments, Strategies, Mergers and Acquisitions and New Product Developments
Published: 2021-12-24 (Crawled : 12:30) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| Email alert Add to watchlist
GLPGF | News | $35.5157 71.75% 4.8K

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| Email alert Add to watchlist
GLPG | News | $29.095 0.64% 0.64% 87K

Health Technology

| Email alert Add to watchlist
acquisition new product rheumatoid arthritis acquisitions merge

Nodexus Inc. Emerges from Stealth with $30 Million Series A Funding to Advance Manufacturing and Expand Commercialization of NX One Platform
Published: 2021-12-16 (Crawled : 13:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -14.83% | O: 0.59% H: 0.0% C: 0.0%
commercialization funding platform merge

Lilly's bamlanivimab with etesevimab authorized as the first and only neutralizing antibody therapy for emergency use in COVID-19 patients under the age of 12
Published: 2021-12-03 (Crawled : 20:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| Email alert Add to watchlist
covid therapy authorized antibody merge

Health Canada announces results of Emergent BioSolutions facility inspection
Published: 2021-11-24 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.38% | O: 0.2% H: 0.0% C: 0.0%
results merge health

U.S. Government Cancels Contract with Embattled Emergent BioSolutions
Published: 2021-11-05 (Crawled : 16:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -12.05% | O: -1.31% H: 0.0% C: 0.0%
contract merge

2021 Emerging Markets EHS Software Report: Over 40 Major Mergers, Accquisitions and Buyouts in the Last Two Years
Published: 2021-11-03 (Crawled : 15:15) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K

Health Technology

| -8.62% | O: 2.27% H: 0.0% C: -1.06%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -12.46% | O: -0.34% H: 0.0% C: 0.0%
ACM | $93.35 0.12% 0.0% 540K

Industrial Services

| 35.46% | O: -0.28% H: 0.12% C: -0.01%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| -12.36% | O: 0.54% H: 0.0% C: 0.0%
software merge

Global Nicotine Gum Market Report 2021: Emergence of e-Cigarettes has Considerably Challenged Market Growth
Published: 2021-10-28 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510

Health Technology

| -0.88% | O: 1.37% H: 0.0% C: 0.0%
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| -32.72% | O: -0.31% H: 1.77% C: 1.44%
NVS | $94.36 1.93% 0.0% 2.3M

Health Technology

| 11.73% | O: -0.84% H: 0.18% C: 0.18%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -10.99% | O: -0.31% H: 0.55% C: 0.33%
GSK | News | $39.75 1.22% 0.0% 1.6M

Health Technology

| -5.98% | O: -0.33% H: 0.86% C: 0.83%
growth merge market

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA
Published: 2021-10-20 (Crawled : 23:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -11.5% | O: 0.32% H: 0.05% C: -0.55%
covid fda authorized vaccine merge covid-19

Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee
Published: 2021-10-15 (Crawled : 21:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -9.47% | O: 0.58% H: 0.0% C: 0.0%
covid fda vaccine merge emergency use authorization

Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine
Published: 2021-10-05 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.96% | O: 0.4% H: 0.78% C: -0.18%
covid fda vaccine merge submission authorized emergency use authorization

Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine
Published: 2021-10-05 (Crawled : 11:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -8.96% | O: 0.4% H: 0.78% C: -0.18%
covid fda vaccine merge submission authorized emergency use authorization

Emergency Use Authorization for Lilly's bamlanivimab and etesevimab administered together expanded to include post-exposure prophylaxis for COVID-19
Published: 2021-09-16 (Crawled : 22:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -12.37% | O: 0.14% H: 0.49% C: -0.26%
LLY | News | $726.31 -2.63% -0.04% 3.5M

Health Technology

| 221.21% | O: 0.15% H: 0.26% C: -1.3%
covid merge authorized emergency use authorization

Global Molecular Diagnostics Markets, 2021-2028: New Product Launches, Mergers and Acquisitions, Expansion, Partnerships, Marketing & Promotions, Market Entry Strategies
Published: 2021-09-10 (Crawled : 12:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -13.76% | O: 0.26% H: 0.0% C: 0.0%
DHR | $235.51 -0.36% 0.0% 2.3M

Health Technology

| -26.81% | O: 0.58% H: 0.0% C: 0.0%
BIO | $279.73 -0.46% 0.0% 290K

Health Technology

| -66.36% | O: 0.38% H: 0.0% C: 0.0%
BDX | $234.12 0.42% 0.0% 1.3M

Health Technology

| -11.2% | O: 0.19% H: 0.27% C: -0.89%
A | $132.73 0.22% 0.0% 1.3M

Health Technology

| -22.81% | O: 0.28% H: 0.89% C: -0.28%
ILMN | $117.43 0.63% 0.63% 1.4M

Health Technology

| -74.24% | O: 0.53% H: 0.0% C: 0.0%
HOLX | $75.37 0.36% 0.36% 1.3M

Health Technology

| -6.29% | O: -0.01% H: 1.38% C: 0.06%
molecular diagnostics partnership acquisition expansion molecular acquisitions new product diagnostics merge market diagnostic

Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
Published: 2021-08-26 (Crawled : 00:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -16.36% | O: 0.57% H: 0.0% C: 0.0%
GILD | $66.77 0.92% 0.91% 11M

Health Technology

| -6.34% | O: -0.17% H: 1.6% C: -0.04%
FBIO | $1.765 -2.49% -2.55% 190K

Health Technology

| -43.04% | O: 0.65% H: 5.79% C: 4.5%
merge bioscience

Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors
Published: 2021-08-13 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M

Health Technology

| -46.19% | O: 0.55% H: 0.0% C: 0.0%
MYOV | $26.98 -0.04% 0.0% 0

Health Technology

| 22.25% | O: 0.27% H: 0.0% C: 0.0%
MS | News | $90.66 0.44% 0.07% 8.1M

Finance

| -13.37% | O: -0.11% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -17.27% | O: -0.09% H: 0.0% C: 0.0%
F | $12.14 0.66% 0.0% 39M

Consumer Durables

| -13.02% | O: 0.04% H: 0.0% C: 0.0%
CS | $0.8858 1.49% 64M

Finance

| -91.51% | O: -0.34% H: 0.0% C: 0.0%
EXAS | $60.97 -3.95% -4.12% 2.2M

Health Technology

| -33.71% | O: 1.64% H: 0.0% C: 0.0%
DMTK 4 | $0.6423 8.68% 7.99% 660K

Health Technology

| -98.35% | O: 0.86% H: 0.0% C: 0.0%
NMTR | $0.0722 -42.97% -67.9% 10M

Health Technology

| -93.19% | O: -0.94% H: 0.0% C: 0.0%
merge

Emergent’s Woes Are Dire but Not Insurmountable, Legal Expert Says
Published: 2021-08-11 (Crawled : 18:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -16.59% | O: 0.28% H: 0.13% C: -0.26%
merge